Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Mar 15

PMID 33718374

Citations 6

Authors

Rui Chang

Ying Zhu

Jing Xu

Lin Chen

Guannan Su

Aize Kijlstra

Peizeng Yang

Affiliations

Soon will be listed here.

Abstract

The diagnosis of Vogt-Koyanagi-Harada (VKH) disease is mainly based on a complex clinical manifestation while it lacks objective laboratory biomarkers. To explore the potential molecular biomarkers for diagnosis and disease activity in VKH, we performed an untargeted urine metabolomics analysis by ultra-high-performance liquid chromatography equipped with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF/MS). Through univariate and multivariate statistical analysis, we found 9 differential metabolites when comparing VKH patients with healthy controls, and 26 differential metabolites were identified when comparing active VKH patients with inactive VKH patients. Pathway enrichment analysis showed that glycine, serine and threonine metabolism, and arginine and proline metabolism were significantly altered in VKH versus healthy controls. Lysine degradation and biotin metabolism pathways were significantly altered in active VKH versus inactive VKH. Furthermore, the receiver operating characteristic (ROC) curve analysis revealed that the combination of acetylglycine and gamma-glutamylalanine could differentiate VKH from healthy controls with an area under the curve (AUC) of 0.808. A combination of ureidopropionic acid and 5'-phosphoribosyl-5-amino-4-imidazolecarboxamide (AICAR) had an excellent AUC of 0.958 for distinguishing active VKH from inactive VKH. In summary, this study identified abnormal metabolites in urine of patients with VKH disease. Further studies are needed to confirm whether these metabolites are specific for this disease.

Citing Articles

Intestinal metabolomics in premature infants with late-onset sepsis.

Liu J, Zhang L, Li D, Yu X, Gao Y, Zhou Y Sci Rep. 2024; 14(1):4659.

PMID: 38409213 PMC: 10897474. DOI: 10.1038/s41598-024-55398-7.

OR11H1 Missense Variant Confers the Susceptibility to Vogt-Koyanagi-Harada Disease by Mediating Gadd45g Expression.

Li X, Wang G, Wang X, Li W, Li N, Liu X Adv Sci (Weinh). 2024; 11(11):e2306563.

PMID: 38168905 PMC: 10953539. DOI: 10.1002/advs.202306563.

Metabolomic profiling of a neurodegenerative retina following optic nerve transection.

Zhu J, Ni X, Han X, Liu S, Ji Y, Yao J Mol Med Rep. 2023; 28(3).

PMID: 37539744 PMC: 10433715. DOI: 10.3892/mmr.2023.13065.

Classification of Vogt-Koyanagi-Harada disease using feature selection and classification based on wide-field swept-source optical coherence tomography angiography.

Xiao P, Ma K, Ye X, Wang G, Duan Z, Huang Y Front Bioeng Biotechnol. 2023; 11:1086347.

PMID: 37200845 PMC: 10185775. DOI: 10.3389/fbioe.2023.1086347.

Clinical Comparative Study of Different Fundus Imaging Methods in the Acute Phase of Vogt-Koyanagi-Harada Disease.

Wu H, Hu L, Tang W, Chen G, Liu J, Li S Evid Based Complement Alternat Med. 2022; 2022:5812090.

PMID: 36262163 PMC: 9576379. DOI: 10.1155/2022/5812090.

References

Polevoda B, Sherman F . The diversity of acetylated proteins. Genome Biol. 2002; 3(5):reviews0006. PMC: 139359. DOI: 10.1186/gb-2002-3-5-reviews0006. View

Rinschen M, Ivanisevic J, Giera M, Siuzdak G . Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol. 2019; 20(6):353-367. PMC: 6613555. DOI: 10.1038/s41580-019-0108-4. View

Fernandez-Ochoa A, Quirantes-Pine R, Borras-Linares I, Gemperline D, Alarcon Riquelme M, Beretta L . Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients. J Pharm Biomed Anal. 2018; 162:82-90. DOI: 10.1016/j.jpba.2018.09.021. View

Weisz J, Holland G, Roer L, Park M, Yuge A, Moorthy R . Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology. 1995; 102(7):1012-5. DOI: 10.1016/s0161-6420(95)30920-7. View

Yang X, Xia R, Yue C, Zhai W, Du W, Yang Q . ATF4 Regulates CD4 T Cell Immune Responses through Metabolic Reprogramming. Cell Rep. 2018; 23(6):1754-1766. PMC: 6051420. DOI: 10.1016/j.celrep.2018.04.032. View

Marchesi J, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F . Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007; 6(2):546-51. DOI: 10.1021/pr060470d. View

Van den Eynden J, Ali S, Horwood N, Carmans S, Brone B, Hellings N . Glycine and glycine receptor signalling in non-neuronal cells. Front Mol Neurosci. 2009; 2:9. PMC: 2737430. DOI: 10.3389/neuro.02.009.2009. View

Li M, Zhao M, Gao Y . Changes of proteins induced by anticoagulants can be more sensitively detected in urine than in plasma. Sci China Life Sci. 2014; 57(7):649-56. DOI: 10.1007/s11427-014-4661-y. View

Du L, Kijlstra A, Yang P . Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016; 52:84-111. DOI: 10.1016/j.preteyeres.2016.02.002. View

10.

Sakata V, da Silva F, Hirata C, de Carvalho J, Yamamoto J . Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev. 2014; 13(4-5):550-5. DOI: 10.1016/j.autrev.2014.01.023. View

11.

Verhagen F, Stigter E, Pras-Raves M, Burgering B, Imhof S, Radstake T . Aqueous Humor Analysis Identifies Higher Branched Chain Amino Acid Metabolism as a Marker for Human Leukocyte Antigen-B27 Acute Anterior Uveitis and Disease Activity. Am J Ophthalmol. 2018; 198:97-110. DOI: 10.1016/j.ajo.2018.10.004. View

12.

Jabs D, Nussenblatt R, Rosenbaum J . Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140(3):509-16. PMC: 8935739. DOI: 10.1016/j.ajo.2005.03.057. View

13.

Liu Z, Zhu H, Wang W, Xu J, Que S, Zhuang L . Metabonomic Profile of Macrosteatotic Allografts for Orthotopic Liver Transplantation in Patients With Initial Poor Function: Mechanistic Investigation and Prognostic Prediction. Front Cell Dev Biol. 2020; 8:826. PMC: 7484052. DOI: 10.3389/fcell.2020.00826. View

14.

Yan R, Jiang H, Gu S, Feng N, Zhang N, Lv L . Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study. Front Immunol. 2020; 11:2138. PMC: 7511511. DOI: 10.3389/fimmu.2020.02138. View

15.

Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y . Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005; 30(11):943-8. DOI: 10.1080/02713680500263606. View

16.

Chi W, Yang P, Li B, Wu C, Jin H, Zhu X . IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007; 119(5):1218-24. DOI: 10.1016/j.jaci.2007.01.010. View

17.

Kelly B, Pearce E . Amino Assets: How Amino Acids Support Immunity. Cell Metab. 2020; 32(2):154-175. DOI: 10.1016/j.cmet.2020.06.010. View

18.

Alonso A, Julia A, Vinaixa M, Domenech E, Fernandez-Nebro A, Canete J . Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med. 2016; 14(1):133. PMC: 5016926. DOI: 10.1186/s12916-016-0681-8. View

19.

Chang R, Chen L, Su G, Du L, Qin Y, Xu J . Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene. J Autoimmun. 2020; 112:102465. DOI: 10.1016/j.jaut.2020.102465. View

20.

Chen L, Chang R, Pan S, Xu J, Cao Q, Su G . Plasma metabolomics study of Vogt-Koyanagi-Harada disease identifies potential diagnostic biomarkers. Exp Eye Res. 2020; 196:108070. DOI: 10.1016/j.exer.2020.108070. View